Related Experiment Video

Updated: May 4, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.0K

Vaccine profile of 4CMenB: a four-component Neisseria meningitidis serogroup B vaccine

Susanna Esposito1, Nicola Principi

  • 1Department of Pathophysiology and Transplantation, Pediatric Highly Intensive Care Unit, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Expert Review of Vaccines
|January 8, 2014
PubMed

Insights

The four-component vaccine (4CMenB) shows promise against Neisseria meningitidis serogroup B (MenB) invasive disease in children. Further research is needed to confirm long-term effectiveness and safety before widespread use.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup B (MenB) is a severe condition with significant morbidity and mortality.
  • The development of MenB vaccines is crucial for public health due to the severity of MenB infections.

Purpose of the Study:

  • To evaluate the immunogenicity and in vitro efficacy of the four-component MenB vaccine (4CMenB).
  • To identify areas requiring further investigation for the universal recommendation of 4CMenB.

Main Methods:

  • The study involved testing 4CMenB in animal models and human pediatric subjects.
  • In vitro assays were used to assess vaccine effectiveness against various MenB strains.

Main Results:

  • 4CMenB demonstrated immunogenicity in pediatric populations.
  • The vaccine showed in vitro effectiveness against a majority of MenB strains tested.

Conclusions:

  • While promising, 4CMenB requires further evaluation regarding long-term coverage, protection duration, simplified administration, rare adverse events, carrier impact, and cost-effectiveness.
  • Additional studies are necessary to fully characterize the vaccine's profile and support universal recommendations.

More Related Videos

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

9.8K

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
175
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Vaccinations01:51

Vaccinations

Overview
44.1K